Genmab
Genmab is an international biotechnology company with a core purpose to improve the lives of people with cancer. To develop and deliver novel therapies to patients, Genmab has formed 20+ strategic partnerships with biotechnology and pharmaceutical companies. Genmab’s proprietary pipeline includes bispecific T-cell engagers, next-generation immune checkpoint modulators, effector function enhanced antibodies and antibody-drug conjugates. Visit us at Genmab.com or Twitter.com/Genmab.